It was also proven that one of the protopanaxadiol derivatives—ginsenoside Rb1—improves fatigue syndrome by reducing skeletal muscle oxidative stress through activation of the PI3K/Akt/Nrf2 pathway in aged rats [92]. Here, AKT1 is linked to Fatigue.